Search Results - "KURAJOH, MASAFUMI"

Uric acid shown to contribute to increased oxidative stress level independent of xanthine oxidoreductase activity in MedCity21 health examination registry by Kurajoh, Masafumi, Fukumoto, Shinya, Yoshida, Shio, Akari, Seigo, Murase, Takayo, Nakamura, Takashi, Ishii, Haruka, Yoshida, Hisako, Nagata, Yuki, Morioka, Tomoaki, Mori, Katsuhito, Imanishi, Yasuo, Hirata, Kazuto, Emoto, Masanori

“…Uric acid has both antioxidant and pro-oxidant properties in vitro by scavenging and production of reactive oxygen species (ROS) . This cross-sectional study…”
Get full text

Retroperitoneal Bronchogenic Cyst Adjacent to Adrenocortical Adenoma by Toi, Norikazu, Kurajoh, Masafumi, Noda, Satoru, Emoto, Masanori

Get full text

Recent Advances in Dysuricemia: Toward Optimal Serum Urate Level by Kurajoh, Masafumi, Nakayama, Akiyoshi

“…We are pleased to present the Special Issue "Dysuricemia: Recent Advances in Urate Research from Hypouricemia to Hyperuricemia/Gout" [...]…”
Get full text

Association of plasma xanthine oxidoreductase activity with blood pressure affected by oxidative stress level: MedCity21 health examination registry by Yoshida, Shio, Kurajoh, Masafumi, Fukumoto, Shinya, Murase, Takayo, Nakamura, Takashi, Yoshida, Hisako, Hirata, Kazuto, Inaba, Masaaki, Emoto, Masanori

“…Xanthine oxidoreductase (XOR) inhibitor administration reduces uric acid and reactive oxygen species (ROS) production, and also lowers blood pressure (BP)…”
Get full text

Improvement in the mobility of a patient with fibroblast growth factor 23-related hypophosphatemic osteomalacia and decompensated liver cirrhosis in response to burosumab: a case report by Toi, Norikazu, Imanishi, Yasuo, Nagata, Yuki, Kurajoh, Masafumi, Morioka, Tomoaki, Shoji, Tetsuo, Shinto, Yoshitaka, Emoto, Masanori

“…Acquired fibroblast growth factor (FGF) 23-related hypophosphatemic osteomalacia is characterized clinically by muscle weakness, bone pain, and fractures. Its…”
Get full text

Seasonal variations for newly prescribed urate-lowering drugs for asymptomatic hyperuricemia and gout in Japan by Kurajoh, Masafumi, Akari, Seigo, Nakamura, Takashi, Ihara, Yasutaka, Imai, Takumi, Morioka, Tomoaki, Emoto, Masanori

“…Urate-lowering drugs (ULDs) have been approved for treatment of asymptomatic hyperuricemia and gout in Japan. Although serum urate levels and rates of gout…”
Get full text

U-shaped relationship between serum uric acid levels and intrarenal hemodynamic parameters in healthy subjects by Uedono, Hideki, Tsuda, Akihiro, Ishimura, Eiji, Nakatani, Shinya, Kurajoh, Masafumi, Mori, Katsuhito, Uchida, Junji, Emoto, Masanori, Nakatani, Tatsuya, Inaba, Masaaki

“…Hyperuricemia has been reported to affect renal hemodynamics. In a recent study, both low and high levels of serum uric acid (SUA) were found to be associated…”
Get more information

Effects of denosumab as compared with parathyroidectomy regarding calcium, renal, and bone involvement in osteoporotic patients with primary hyperparathyroidism by Miyaoka, Daichi, Imanishi, Yasuo, Kato, Eiko, Toi, Norikazu, Nagata, Yuki, Kurajoh, Masafumi, Yamada, Shinsuke, Inaba, Masaaki, Emoto, Masanori

“…Purpose To evaluate the effects of denosumab (Dmb) on calcium, renal, and bone involvement in osteoporotic patients with primary hyperparathyroidism (PHPT) and…”
Get full text

Bazedoxifene improves renal function and increases renal phosphate excretion in patients with postmenopausal osteoporosis by Masaki, Hideki, Imanishi, Yasuo, Naka, Hiroshi, Nagata, Yuki, Kurajoh, Masafumi, Mori, Katsuhito, Emoto, Masanori, Miki, Takami, Inaba, Masaaki

“…Introduction Because aging is a predictor of renal insufficiency in the general population, renal function is a concern in postmenopausal patients undergoing…”
Get full text

Multifaceted Nutritional Disorders in Elderly Patients Undergoing Dialysis by Mori, Katsuhito, Kurajoh, Masafumi, Inaba, Masaaki, Emoto, Masanori

“…Advances in medicine have resulted in increased longevity, which has consequently led to unexpected geriatric syndromes, such as frailty and sarcopenia…”
Get full text

Role of adiponectin in the relationship between visceral adiposity and fibroblast growth factor 23 in non-diabetic men with normal kidney function by Natsuki, Yuka, Morioka, Tomoaki, Fukumoto, Shinya, Kakutani, Yoshinori, Yamazaki, Yuko, Ochi, Akinobu, Kurajoh, Masafumi, Mori, Katsuhito, Shoji, Tetsuo, Imanishi, Yasuo, Inaba, Masaaki, Emoto, Masanori

“…Fibroblast growth factor 23 (FGF23) is a key regulator of phosphate metabolism. Circulating FGF23 levels are associated with obesity, metabolic syndrome, and…”
Get full text

Bexarotene-induced central hypothyroidism assessed by TRH stimulation test in cutaneous T-cell lymphoma patients by Toi, Norikazu, Kurajoh, Masafumi, Miyaoka, Daichi, Nagata, Yuki, Yamada, Shinsuke, Imanishi, Yasuo, Hayashi, Daisuke, Tateishi, Chiharu, Inaba, Masaaki, Tsuruta, Daisuke, Morita, Akimichi, Emoto, Masanori

“…Bexarotene-induced central hypothyroidism (CH), for which levothyroxine (LT4) replacement is recommended, has been shown to be caused by pituitary but not…”
Get full text

Glycated hemoglobin level on admission associated with progression to severe disease in hospitalized patients with non‐severe coronavirus disease 2019 by Numaguchi, Ryutaro, Kurajoh, Masafumi, Hiura, Yoshikazu, Imai, Takumi, Morioka, Tomoaki, Saito, Mika, Shiraishi, Satoshi, Emoto, Masanori, Nishiguchi, Yukio

“…Aims/Introduction Poor glycemic control is known to be associated with severe infection development. This retrospective observational study examined whether…”
Get full text

A case of central diabetes insipidus after COVID-19 as a probable diagnosis of lymphocytic infundibulo-neurohypophysitis with positive anti-rabphilin-3A antibodies with review of literature by Natsuki, Yuka, Nagata, Yuki, Nagasaki, Toshiki, Morimoto, Mari, Toi, Norikazu, Kurajoh, Masafumi, Morioka, Tomoaki, Shoji, Tetsuo, Imanishi, Yasuo, Iwata, Naoko, Fujisawa, Haruki, Suzuki, Atsushi, Sugimura, Yoshihisa, Emoto, Masanori

“…Coronavirus disease 2019 (COVID-19) is caused by severe acute respiratory syndrome coronavirus 2, and various complications have been reported. Furthermore,…”
Get full text

Serum Fibroblast Growth Factor 23 Levels are Associated with Vascular Smooth Muscle Dysfunction in Type 2 Diabetes by Natsuki, Yuka, Morioka, Tomoaki, Kakutani, Yoshinori, Yamazaki, Yuko, Ochi, Akinobu, Kurajoh, Masafumi, Mori, Katsuhito, Imanishi, Yasuo, Shoji, Tetsuo, Inaba, Masaaki, Emoto, Masanori

“…Aim: Increased level of serum fibroblast growth factor 23 (FGF23) is a hallmark of abnormal phosphate metabolism in patients with chronic kidney disease (CKD)…”
Get full text

Association of xanthine oxidoreductase inhibitor use with insulin secretory capacity in patients with type 2 diabetes by Kitamura, Atsushi, Kurajoh, Masafumi, Miki, Yuya, Kakutani, Yoshinori, Yamazaki, Yuko, Ochi, Akinobu, Morioka, Tomoaki, Mori, Katsuhito, Shoji, Tetsuo, Emoto, Masanori

“…ABSTRACT Aim/Introduction Xanthine oxidoreductase (XOR) inhibitor treatment, which reduces reactive oxygen species (ROS) production and increases adenosine…”
Get full text

Possible role of insulin resistance in activation of plasma xanthine oxidoreductase in health check-up examinees by Kurajoh, Masafumi, Fukumoto, Shinya, Akari, Seigo, Murase, Takayo, Nakamura, Takashi, Takahashi, Kanae, Yoshida, Hisako, Nakatani, Shinya, Tsuda, Akihiro, Morioka, Tomoaki, Mori, Katsuhito, Imanishi, Yasuo, Hirata, Kazuto, Emoto, Masanori

“…We previously found an association of insulin resistance (IR) with plasma xanthine oxidoreductase (XOR) activity in a cross-sectional study. However, whether…”
Get full text

Plasma omentin levels are inversely associated with atherosclerosis in type 2 diabetes patients with increased plasma adiponectin levels: a cross-sectional study by Nishimura, Masami, Morioka, Tomoaki, Hayashi, Mariko, Kakutani, Yoshinori, Yamazaki, Yuko, Kurajoh, Masafumi, Mori, Katsuhito, Fukumoto, Shinya, Shioi, Atsushi, Shoji, Tetsuo, Inaba, Masaaki, Emoto, Masanori

“…Omentin and adiponectin are among the anti-inflammatory and anti-atherogenic adipokines that have potentially beneficial effects on cardiovascular disorders…”
Get full text

Association of cystatin C- and creatinine-based eGFR with osteoporotic fracture in Japanese postmenopausal women with osteoporosis: sarcopenia as risk for fracture by Kurajoh, Masafumi, Inaba, Masaaki, Nagata, Yuki, Yamada, Shinsuke, Imanishi, Yasuo, Emoto, Masanori

“…Coexistence of chronic kidney disease (CKD) is regarded as a risk for osteoporotic fracture particularly in postmenopausal women, not only because of increased…”
Get full text

Attenuated Dentin Matrix Protein 1 Enhances Fibroblast Growth Factor 23 in Calvaria in a Primary Hyperparathyroidism Model by Nagata, Yuki, Imanishi, Yasuo, Ohara, Masaya, Maeda-Tateishi, Tomomi, Miyaoka, Daichi, Hayashi, Noriyuki, Kurajoh, Masafumi, Emoto, Masanori, Inaba, Masaaki

“…Fibroblast growth factor 23 (FGF23) secretion is facilitated by the PTH, particularly in hyperparathyroidism. The PTH also attenuates dentin matrix protein 1…”
Get full text